William Blair initiated coverage of Zealand Pharma (ZLDPF) with a Market Perform rating.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- Zealand Pharma price target lowered to DKK 1,050 from DKK 1,080 at Berenberg
- Zealand Pharma’s Earnings Call: Clinical Gains and Challenges
- Zealand Pharma price target lowered to DKK 750 from DKK 755 at Morgan Stanley
- Zealand Pharma Reports Transformative Year with Strong R&D Focus
- ZLDPF Earnings this Week: How Will it Perform?